Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1993 1
1994 2
1995 1
1996 3
1997 1
1998 2
1999 5
2000 2
2005 6
2006 2
2007 4
2008 4
2009 2
2010 2
2011 5
2012 5
2013 6
2014 5
2015 5
2016 3
2018 2
2019 3
2020 8
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

71 results
Results by year
Filters applied: . Clear all
Page 1
Salvage Radiotherapy Versus Hormone Therapy for Prostate-specific Antigen Failure After Radical Prostatectomy: A Randomised, Multicentre, Open-label, Phase 3 Trial (JCOG0401)†.
Yokomizo A, Wakabayashi M, Satoh T, Hashine K, Inoue T, Fujimoto K, Egawa S, Habuchi T, Kawashima K, Ishizuka O, Shinohara N, Sugimoto M, Yoshino Y, Nihei K, Fukuda H, Tobisu KI, Kakehi Y, Naito S; JCOG0401 Investigators. Yokomizo A, et al. Among authors: hashine k. Eur Urol. 2020 Jun;77(6):689-698. doi: 10.1016/j.eururo.2019.11.023. Epub 2019 Dec 19. Eur Urol. 2020. PMID: 31866092
Efficacy and safety of abiraterone acetate plus prednisone in Japanese patients with newly diagnosed, metastatic hormone-naive prostate cancer: final subgroup analysis of LATITUDE, a randomized, double-blind, placebo-controlled, phase 3 study.
Suzuki H, Shin T, Fukasawa S, Hashine K, Kitani S, Ohtake N, Shibayama K, Tran N, Mundle S, Fizazi K, Matsubara N. Suzuki H, et al. Among authors: hashine k. Jpn J Clin Oncol. 2020 Jul 9;50(7):810-820. doi: 10.1093/jjco/hyaa030. Jpn J Clin Oncol. 2020. PMID: 32188988 Free PMC article. Clinical Trial.
Characteristic distribution of maculopapular rash caused by gemcitabine-based chemotherapy.
Tohyama M, Asagi A, Nakasya A, Iuchi S, Hashine K. Tohyama M, et al. Among authors: hashine k. J Dermatol. 2020 Nov 11. doi: 10.1111/1346-8138.15654. Online ahead of print. J Dermatol. 2020. PMID: 33179309
Patient-reported outcomes after open radical prostatectomy, laparoscopic radical prostatectomy and permanent prostate brachytherapy.
Hashine K, Kakuda T, Iuchi S, Tomida R, Matsumura M. Hashine K, et al. Jpn J Clin Oncol. 2019 Dec 18;49(11):1037-1042. doi: 10.1093/jjco/hyz116. Jpn J Clin Oncol. 2019. PMID: 31436793
A randomized phase III trial of personalized peptide vaccination for castration‑resistant prostate cancer progressing after docetaxel.
Noguchi M, Fujimoto K, Arai G, Uemura H, Hashine K, Matsumoto H, Fukasawa S, Kohjimoto Y, Nakatsu H, Takenaka A, Fujisawa M, Uemura H, Naito S, Egawa S, Fujimoto H, Hinotsu S, Itoh K. Noguchi M, et al. Among authors: hashine k. Oncol Rep. 2021 Jan;45(1):159-168. doi: 10.3892/or.2020.7847. Epub 2020 Nov 11. Oncol Rep. 2021. PMID: 33200227 Free PMC article.
Health-related quality of life in Japanese low-risk prostate cancer patients choosing active surveillance: 3-year follow-up from PRIAS-JAPAN.
Hirama H, Sugimoto M, Miyatake N, Kato T, Venderbos LDF, Remmers S, Shiga K, Yokomizo A, Mitsuzuka K, Matsumoto R, Osawa T, Abe T, Sasaki H, Egawa S, Ninomiya I, Hashine K, Roobol MJ, Kakehi Y. Hirama H, et al. Among authors: hashine k. World J Urol. 2020 Oct 20. doi: 10.1007/s00345-020-03494-4. Online ahead of print. World J Urol. 2020. PMID: 33079252
An open-label, phase 1 study of androgen receptor antagonist, apalutamide in Japanese patients with metastatic castration-resistant prostate cancer.
Tsuchiya T, Imanaka K, Iwaki Y, Oyama R, Hashine K, Yamaguchi A, Uemura H. Tsuchiya T, et al. Among authors: hashine k. Int J Clin Oncol. 2019 Dec;24(12):1596-1604. doi: 10.1007/s10147-019-01526-7. Epub 2019 Aug 24. Int J Clin Oncol. 2019. PMID: 31446511 Free PMC article. Clinical Trial.
Significance of the timing of ureteral ligation on prognosis during radical nephroureterectomy for upper urinary tract urothelial cancer.
Inokuchi J, Kuroiwa K, Nishiyama H, Kojima T, Kakehi Y, Sugimoto M, Takenaka A, Fujimoto K, Yamaguchi R, Habuchi T, Hashine K, Mizusawa J, Eba J, Naito S; Urologic Oncology Study Group of the Japan Clinical Oncology Group (JCOG). Inokuchi J, et al. Among authors: hashine k. Int J Urol. 2020 Nov 29. doi: 10.1111/iju.14435. Online ahead of print. Int J Urol. 2020. PMID: 33283389
The impact of complications after initial prostate biopsy on repeat protocol biopsy acceptance rate. Results from the Prostate Cancer Research International: Active Surveillance JAPAN study.
Tohi Y, Kato T, Matsumoto R, Shinohara N, Shiga K, Yokomizo A, Nakamura M, Kume H, Mitsuzuka K, Sasaki H, Egawa S, Matsumura M, Hashine K, Inokuchi J, Eto M, Baba H, Ichikawa T, Kinoshita H, Matsuda T, Kakehi Y, Sugimoto M. Tohi Y, et al. Among authors: hashine k. Int J Clin Oncol. 2020 Dec;25(12):2107-2114. doi: 10.1007/s10147-020-01761-3. Epub 2020 Aug 8. Int J Clin Oncol. 2020. PMID: 32770439
Oncological outcomes for patients with locally advanced prostate cancer treated with neoadjuvant endocrine and external-beam radiation therapy followed by adjuvant continuous/intermittent endocrine therapy in an open-label, randomized, phase 3 trial.
Ito K, Kobayashi M, Komiyama M, Naito S, Nishimura K, Yonese J, Hashine K, Saito S, Arai G, Shinohara M, Masumori N, Shimizu N, Satoh T, Yamauchi A, Tochigi T, Takezawa Y, Fujimoto H, Yokomizo A, Kakimoto KI, Fukui I, Karasawa K, Tsukamoto T, Nozaki M, Hasumi M, Ishiyama H, Ohtani M, Kuwahara M, Harada M, Ohashi Y, Kotake T, Kakizoe T, Suzuki K, Yamanaka H; National Research Project on Endocrine-Radiation Combination Therapy for Locally Advanced Prostate Cancer Investigators. Ito K, et al. Among authors: hashine k. Cancer. 2020 Sep 1;126(17):3961-3971. doi: 10.1002/cncr.33034. Epub 2020 Jun 23. Cancer. 2020. PMID: 32573779
71 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback